Ann: HER-Vaxx and CF33 Platforms Featured at ASCO Symposium, page-14

There is relentless selling pressure. Despite there being more buyers than sellers, there is significantly more sell shares than buy shares.
The share price has been in a tight range for a while and every attempt at getting the price up is met with more resistance to keep the share price at bay. Lets hope it is someone trying to accumulate at the lowest price possible. Still think that to reverse this trend requires a significant positive clinical result or an announcement of an interested BP.

The problem at the moment is that all positive announcements (whether price sensitive or not) is met with a muted response. This does not auger well if there was ever to be a negative announcement. In fact I think the share price will be smashed if there was to be a negative announcement especially to do with trial results. At the moment any down days on the ASX is a good excuse to drive the share price down whilst good days on the ASX for share price takes a rest.